Endovascular Treatment of Popliteal Artery - Balloon Angioplasty Versus Primary Stenting

Inclusion Criteria: * The patient is at least 21 years old * The patient or legal representative provided written informed consent * The patient agrees to comply with the protocol-mandated follow-up visits and testing regime * The patient has lifestyle-limiting claudication or critical limb ischemia defined as: Fontaine stage IIa-IV/ Rutherford 1-5 category * The target lesion located within the popliteal artery has angiographic evidence of stenosis \> 70% or occlusion (by visual estimate) * At least one vessel runoff to the foot * The patient has no other relevant inflow or outflow stenosis (\> 50%), however when needed iliac or femoral intervention may be done during study procedure. Exclusion Criteria: * The patient is currently participating in a drug or another device study. * The popliteal artery target lesion has previously been subintimal recanalized * The patient has a history of bleeding diatheses or coagulopathy * Female patients that are pregnant * The patient has a contraindication (including allergic reaction) to platelet aggregation inhibitors or heparin * The patient is unable to conform to the study protocol follow-up procedures or visits. * The patient has a life expectancy of \<24 months * The patient has concomitant renal failure which requires dialysis * The patient has a contraindication (including allergic reaction) to or a known sensitivity to contrast media * The duplex ultrasound/angiography of the target lesion must NOT meet the following criteria: * The popliteal artery target lesion stenosis/occlusion is also continuously located within the superficial femoral artery and/or tibiofibular tract * The popliteal artery target lesion is restenotic * The popliteal artery has been subintimal recanalized